Navigation Links
Michael J. Fox Foundation Names Core Programs in Honor of Humanitarian Edmond J. Safra
Date:11/3/2008

NEW YORK, Nov. 3 /PRNewswire/ -- At the "A Funny Thing Happened on the Way to Cure Parkinson's Disease" gala benefiting The Michael J. Fox Foundation for Parkinson's Research, to be held this week in New York City, Founder Michael J. Fox will announce that the Foundation has named its core programs in honor of the late philanthropist and humanitarian Edmond J. Safra.

MJFF's Edmond J. Safra Core Programs for PD Research are three annual funding initiatives designed to keep the drug development pipeline for Parkinson's disease flowing with novel, high-impact ideas promising tangible improvements in patients' quality of life sooner rather than later.

In 1999 Mr. Safra founded The Edmond J. Safra Foundation, which has been a generous and steadfast supporter of The Michael J. Fox Foundation's mission to speed progress toward transformative treatments --- and ultimately a cure --- for Parkinson's disease. He shared his devotion to this cause with his beloved wife, Lily, a member of the Board of The Michael J. Fox Foundation and, since her husband's passing, Chairman of The Edmond J. Safra Foundation.

"Lily has been a great personal friend to me, and under her leadership the Edmond J. Safra Foundation has been a dedicated steward of our Foundation's efforts to accelerate the cure," said Michael J. Fox. "It is only appropriate that the programs defining the core of our Foundation's mission to significantly impact patients' lives should serve as a lasting tribute to Edmond J. Safra."

Considered by many to have been among the greatest bankers of his generation, Mr. Safra also was an extraordinary philanthropist. He contributed to countless humanitarian, religious, educational and cultural causes the world over. He was deeply committed to the search for a cure for neurodegenerative diseases, in particular Parkinson's disease, and made the support of medical research in this field one of the key objectives of The Edmond J. Safra Foundation. '/>"/>

SOURCE The Michael J. Fox Foundation for Parkinson?s Research
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine news :

1. Michael Moores SiCKO Becomes the Third Highest Grossing Documentary of All Time Surpassing An Inconvenient Truth
2. Katie Hood Appointed Interim Chief Executive Officer of Michael J. Fox Foundation
3. Clarient Names Michael J. Pellini, M.D. Chief Operating Officer
4. Digital Healthcare Announces Dr. Michael Fleming Joins Executive Team as Medical Director
5. Michael J. Fox Foundation Commits Up to $2 Million for PD Drug Development Under Target Validation 2008
6. BioElectronics Corporation Announces Addition of Michael Seidenman, R.Ph. as Vice President of Sales
7. BioSeek Appoints Michael C. Venuti, Ph.D., Chief Executive Officer
8. Irene Hegeman Richard, MD, Appointed Senior Medical Advisor to The Michael J. Fox Foundation
9. Actress Jenifer Lewis, Authors Dr. Michael Eric Dyson and Susan Taylor Among Featured Speakers for Senator Hughes Behavioral Mental Health Summit
10. Michael J. Fox Foundation Launches Rapid Response Innovation Awards 2008 Following Strong Inaugural Year Response
11. Siemens Medical Solutions Michael Long Recognized as one of Computerworlds 2008 Premier 100 IT Leaders

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)... 2009 Shire plc (LSE: SHP, NASDAQ: SHPGY), the gl...nounced the availability of INTUNIV (guanfacine) E...nited States for the treatment of Attention-Defici...olescents ages 6 to 17. INTUNIV, a once-daily for...cheduled alpha-2A receptor agonist approved for th...
(Date:11/9/2009)...ple around the world suffer from cataracts. Thomas...his coauthors discuss cataract surgery with the im...sue of Deutsches rzteblatt International ( Dtsch...ndness is usually due to opacification of the lens...rations are performed each year. Cataracts can be ...
(Date:11/9/2009)... people have tried to read Charles Darwin,s "Origi...0th anniversary this month, but gave up. , For t...k is about, help by way of a new book is at hand. ...eznick is the author of "The Origin Then and N...s " (Princeton University Press, 2009), which mak...
(Date:11/9/2009)...n bias might be the reason why African Americans a...e same rate as similar patients in other racial gr...pancreas transplantation at Georgetown University ...rgetown University Medical Center, and colleagues ...he American Journal of Transplantation . , Med...
(Date:11/9/2009)...risks, but not all agree , , MONDAY, Nov...ine solution might have soothing short-term benefi...nfections in the long run by stripping your nose o...ose, we are removing the bad mucus but, unfortunat...ains the antimicrobial agents as well," said Dr. T...
Breaking Medicine News(10 mins):Health News:Once-daily INTUNIV (guanfacine) extended release tablets now available in US pharmacies 2Health News:Once-daily INTUNIV (guanfacine) extended release tablets now available in US pharmacies 3Health News:Once-daily INTUNIV (guanfacine) extended release tablets now available in US pharmacies 4Health News:Book by UC Riverside biologist explains Darwin's 'Origin of Species' 2Health News:Physician bias might keep life-saving transplants from black and Hispanic patients 2Health News:Sinus Rinses May Do More Harm Than Good 2Health News:Sinus Rinses May Do More Harm Than Good 3
...s begun the second reading of the controversial Me...t's third attempt in eight years to reform the 198...sting legislation on the matter to ensure that pat...hospital will be subject to community treatment or...
...e Group (AMARRG), Dr David Rivett, today congratul...e extension of emergency// medical training as par...and providing more support for GPs to participate....ns on an otherwise positive initiative. The...
...e sources, is touted as a more eco-friendly fuel, ... widespread// use of ethanol could actually pose a... fuel, may not be that eco-friendly after all. The...tmospheric scientist Mark Z. Jacobson says that if...
...ations portraying overall statistics of patients r.../. ART for AIDS has certainly reached many, though...e left out. As per the recent figures, it is...mparison with the figures of last year, there has ...
...ollections of liver tissue samples ever acquired b...esearchers have embarked on a massive study// of o...lcoholic fatty liver disease starts with the accum...lly fatal cirrhosis. If the damage becomes too gre...
...in Florida, USA, a 61-year-old woman caught shopli...e queue to pay her bill as she was suffering from ...able bowel syndrome seems to have been discovered ...d when she was caught shoplifting in Cape Coral, F...
Other Medicine News:Health News:UK Mental Health Reforms Will Do More Harm Than Good, Critics Warn 2Health News:Government Delivers On Emergency Medical Training For Rural Doctors 2Health News:Ethanol Could Be Damaging for Human Health, New Study Says 2Health News:Ethanol Could Be Damaging for Human Health, New Study Says 3Health News:Geisinger Launches Extensive Study on Obesity and Related Liver Problem 2
(Date:11/9/2009)...ewswire/ -- Bend Research Inc., a company,with mor...ve pharmaceutical,technologies to help clients sol...roblems, announced today that it has entered into ...orated, a global biotechnology company,headquarter...ollaboration, Vertex will utilize Bend,s formulati...
(Date:11/9/2009)...wswire-FirstCall/ -- Clarient, Inc. (Nasdaq: CLRT... pathologists, oncologists and the pharmaceutical ...make presentations at two upcoming investor confer...on will be made at the Lazard Capital Markets Sixt...uesday, November 17. The conference will be held a...
(Date:11/7/2009)...wire/ -- Patients reported C1-esterase inhibitor (...ating acute swelling attacks at any body location ...rding to data presented today at the 2009 American...I) Annual Meeting. The results come from a self-re...th the ongoing, prospective, open label I nternat...
Breaking Medicine Technology:Bend Research and Vertex Pharmaceuticals Enter New Scientific Collaboration 2Bend Research and Vertex Pharmaceuticals Enter New Scientific Collaboration 3Clarient to Present at Upcoming Healthcare Investor Conferences in New York City 2Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care 2Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care 3Viral Genetics Completes Second Major Debt Conversion 55463 1Viral Genetics Completes Second Major Debt Conversion 55463 2Viral Genetics Completes Second Major Debt Conversion 55463 3Spokane Washington Man Indicted On Civil Rights Charges Related to Threats to Reproductive Health Services Clinic 55460 1Council for American Medical Innovation Honors Health Champion Senator Edward M Kennedy 55457 1Council for American Medical Innovation Honors Health Champion Senator Edward M Kennedy 55457 2Council for American Medical Innovation Honors Health Champion Senator Edward M Kennedy 55457 3
...le with Diabetes, Hospital,and Professional Charge...URGH, April 02, 2007 /PRNewswire-FirstCall/ -- The...ced today the,release of a new report on the preva...ype 2 diabetes. The inaugural Pittsburgh Type,2 Di...ient,demographics, hospital and professional charg...
...r 3, 2007 - Repros,Therapeutics Inc. (NasdaqGM:RPR... of Proellex(TM), an oral drug being developed to,...uggests that,treatment with Proellex results in a ...mptoms associated with uterine,fibroids and is gen..., This 12 week, double-blind study compared two do...
Other Medicine Technology:State of Diabetes in Pittsburgh: Pittsburgh Business Group on,Health Releases Report 2State of Diabetes in Pittsburgh: Pittsburgh Business Group on,Health Releases Report 3State of Diabetes in Pittsburgh: Pittsburgh Business Group on,Health Releases Report 4Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 2Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 3Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 4Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 5
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
Medicine Products: